RPRX icon

Royalty Pharma

362 hedge funds and large institutions have $10B invested in Royalty Pharma in 2023 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 146 increasing their positions, 110 reducing their positions, and 29 closing their positions.

Holders
362
Holders Change
+50
Holders Change %
+16.03%
% of All Funds
5.31%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.12%
New
79
Increased
146
Reduced
110
Closed
29
Calls
$25.5M
Puts
$17.5M
Net Calls
+$8.06M
Net Calls Change
-$20.6M
Name Market Value Shares Shares
Change
Shares
Change %
VFA
376
Values First Advisors
Tennessee
-8,811 Closed
TCM
377
Teza Capital Management
Illinois
-7,995 Closed
Capstone Investment Advisors
378
Capstone Investment Advisors
New York
-7,700 Closed
BCV
379
Banque Cantonale Vaudoise
Switzerland
-7,200 Closed
SG Americas Securities
380
SG Americas Securities
New York
-5,300 Closed
WBC
381
Westpac Banking Corp
Australia
-2,891 Closed
SGA
382
Seaport Global Advisors
Massachusetts
-2,651 Closed
AS
383
Altshuler Shaham
Israel
-933 Closed
Bessemer Group
384
Bessemer Group
New Jersey
-491 Closed
BAAM
385
Baker Avenue Asset Management
California
-119 Closed
GFPC
386
Global Financial Private Client
Florida
-115 Closed
Northwestern Mutual Wealth Management
387
Northwestern Mutual Wealth Management
Wisconsin
-71 Closed
NFSG
388
Newbridge Financial Services Group
Florida
-50 Closed
CWP
389
Concord Wealth Partners
Virginia
-40 Closed
BIA
390
Bell Investment Advisors
California
-13 Closed
PCM
391
Penserra Capital Management
California
$0 27
NIC
392
Northwest Investment Counselors
Oregon
Group One Trading
393
Group One Trading
Illinois
Capital Fund Management (CFM)
394
Capital Fund Management (CFM)
France
NA
395
NewEdge Advisors
Louisiana
PI
396
PEAK6 Investments
Illinois
Parallax Volatility Advisers
397
Parallax Volatility Advisers
California
Twin Tree Management
398
Twin Tree Management
Texas